Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)

• Status: Completed
• Trial end date: 2004-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the primary preventive effect of low-dose pravastatin against coronary heart disease (CHD) in Japanese hypercholesterolemic patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mitsukoshi Health and Welfare Foundation
• Collaborators: Daiichi Sankyo Co., Ltd.; Ministry of Health, Labour and Welfare, Japan
• Treatments: Pravastatin

Criteria

Inclusion Criteria:

• TC:220～270mg/dl

• Male: 40-70 years old/ female: postmenopausal-70 years old

• <40kg in weight

Exclusion Criteria:

• FH

• History of CHD(angina, MI, post-PTCA/CABG, etc.)

• History of CVA(stroke, TIA, etc.)

• Underlying malignant tumor